Business Wire

Allente Among World’s First Operators to Integrate Google Common Broadcast Stack, supported by KAON and 3SS

24.8.2021 10:00:00 EEST | Business Wire | Press release

Share

3 Screen Solutions (3SS) and KAONMEDIA (KOSDAQ: KAON MEDIA) jointly announce the completion of their hybrid STB (set-top box) integration for Nordic pay-TV giant Allente.

This accomplishment is a milestone achievement which makes Allente one of the world’s first operators to complete Google Common Broadcast Stack integration for an Android TV Operator Tier STB. The project was completed in just six months thanks to close collaboration between Allente, KAONMEDIA, NAGRA, Broadcom, 3SS and Google.

The partnership of 3SS and KAON to deliver Allente’s new service was announced in October 2020. Powerful hybrid KAON BCM72180 PVR STBs will be available to Allente’s over 1 million subscribers, with NAGRA Media CAS, Broadcom 72180 SoC and based on 3SS UX technology, in Q3 2021.

Google created its standardized Common Broadcast Stack (CBS) to accelerate the reach of Android TV OS worldwide. Announced in October 2020, CBS will help more TV viewers to get the next-generation app-rich services they crave. A Broadcast Stack is the software designed for STBs and other TV devices that enables playing and recording of digital TV broadcast signals. Among the positive outcomes of adopting CBS are easier and faster integration for hybrid Android TV OS devices, accelerated time-to-market, simplified upgrades and reduced overall TCO (total cost of ownership). Additionally, with CBS being collectively optimized through Google’s wide-ranging tech partner network, service providers and their subscribers can be even more confident of a superior, next-level Android TV OS viewing experience.

“We congratulate Allente for becoming one of the first operators in the world to leverage the Common Broadcast Stack, and in working closely with world-class technology partners, elevating the digital entertainment user experience for consumers,” commented Matthias Puschmann, Strategic Android TV Partner Development Manager at Google.

The Nordic region’s pre-eminent pay-TV provider, Allente is further building upon its first successful 3SS-enabled project. OnePlace is the satellite and OTT service which Canal Digital launched in February 2018. In 2019 the service was named “Best TV User Experience” in the prestigious CSI Awards. Allente was later formed from the merger of Viasat Consumer and Canal Digital in May 2020, and offers TV via satellite, streaming and other services including IPTV and fibre broadband via open networks to customers in Norway, Sweden, Denmark and Finland.

Allente’s new hybrid KAON BCM72180 PVR STB will give subscribers a range of benefits from high performance to a proven next-gen 3SS-engineered customer experience.

Jon Espen Nergård, Allente CTO, said, “Completion of our STB integration so rapidly is a clear testament to the technology, engineering skill and dedication to customer satisfaction from our partners KAON and 3SS, and indeed those of our wider partnership of collaborators which includes NAGRA, Broadcom and of course Google.”

KAON STB middleware is fully integrated with the Android TV software stack to enable new pre-certified Android TV capabilities such as Custom Over-The-Air Update, among others, further accelerating the introduction of new appealing features.

“We are extremely proud to be the first OEM to complete STB integration on a Broadcom SoC with NAGRA CAS seamlessly integrated with UX delivered by 3SS,” commented Tom Buhl, KAON Media Executive Vice President. “The rapid pace of integration with our highly esteemed partners could hardly be more powerful evidence of the many benefits made possible by the Google Common Broadcast Stack,” he added.

“Our ongoing partnership of trust with Allente is a source of tremendous pride for the entire team at 3SS,” commented Kai-Christian Borchers, Managing Director of 3SS. “In becoming one of the world’s first service providers to embrace Google’s Common Broadcast Stack, Allente is blazing a new trail in innovation and customer focus; we eagerly anticipate helping Allente to deliver leading-edge viewing to consumers in the Nordic region,”

SAFe means speedy integration

This project was accelerated thanks to modern principles of agile development, which were first introduced to Canal Digital by 3SS. At the heart is “SAFe” (Scaled Agile Framework), the practical experience-based software development framework which accelerates and optimizes system deployments.

With SAFe, all stakeholders in a project, both in-house and partners, know the status of objectives and exactly where they are in the progress of a granular roadmap of deliverables. SAFe delivers accelerated, streamlined innovation, better productivity, effective planning and superior products.

Google, Google Play and Android TV are trademarks of Google LLC.

About Allente
Allente is a leading Nordic TV operator, providing top quality TV and broadband services to over 1 million customers in Norway, Sweden, Denmark and Finland. The company was established in May 2020 by a merger between Canal Digital and Viasat Consumer. In 2020, the two companies had combined net sales of SEK 7 billion. Allente is owned 50/50 by Telenor Group and NENT Group. www.allente.se

About KAON
KAON is a technology leader in pay-TV and broadband solutions. We ensure the connected home technology which enables consumers to simply change the way they experience entertainment and information within the home with the full line-up of innovative platforms and service solutions to give users easy access to multi-screen experiences anywhere, at any time. KAONMEDIA is well recognized by Tier 1 Operators in more than 90 countries. Headquartered in South Korea, KAONMEDIA has global presence in over 24 countries including Germany, Norway, France, Spain, Netherlands, Australia, USA, Brazil, Mexico, Colombia, Japan, and others. www.kaonmedia.com

About 3 Screen Solutions (3SS)
Since 2009, 3SS has been delivering world-class software solutions to service providers and technology innovators to bring video to any screen. 3SS is an acknowledged leader in system integration, app development, UI/UX design innovation and solution architecture. 3SS designs and engineers front end and back end platforms for major operators and broadcasters worldwide to make customer experiences easier and more personal. 3SS’ customers include major satellite, cable, IPTV, OTT and mobile TV operators, including Swisscom, Com Hem (Tele2), Allente, Proximus, TCC Uruguay, FreeCast (SelectTV), Altibox, ORS (simpliTV), Yes (STINGTV), Vodafone Kabel Deutschland, Stofa, Liberty Global (UPC, Unitymedia), SES, Eutelsat, and O2/Telefonica. Broadcast customers include ProSiebenSat.1, Joyn (ProSiebenSat.1/Discovery), SUPER RTL (TOGGO), n-tv, Blockbuster and Viacom, among others. 3ss.tv, 3ready.tv

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For KAON
Andrew Shin
+82 31 724 8609
andrew.shin@kaonmedia.com

For 3SS
Cynthia Ritchie
+44 20 3514 2525
cynthia@whitetigercommunications.net

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 11:00:00 EEST | Press release

OM Pharma will reveal preliminary results from the REACH study at the European Academy of Allergy and Clinical Immunology (EAACI) Congress. REACH is the first and largest multi-country real-world evidence (RWE) study to date evaluating the impact of Broncho-Vaxom® in patients with recurrent respiratory tract infections (RTIs).1,2 The findings offer critical new clinical evidence of the therapy's effectiveness in everyday clinical practice. In a real-world cohort of 15,794 paediatric (aged >1 year), adolescent, adult and elderly patients in China, Italy, and Belgium, Broncho-Vaxom® was associated with reductions in RTI recurrence and healthcare utilisation at 12 and 24 months after treatment initiation, compared with the 12 months prior to starting the therapy.1 “The REACH real-world evidence study shows that Broncho-Vaxom® can significantly reduce infections requiring medical visits across age groups and co-morbidities,” said Anna Thomas, Chief Scientific Officer at OM Pharma. “Recurre

Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 18:15:00 EEST | Press release

Incyte (Nasdaq:INCY) today announced updated clinical data from two Phase 1 studies evaluating the safety, tolerability and efficacy of INCA033989, a first-in-class mutant calreticulin (mutCALR)-targeted monoclonal antibody, in patients with mutCALR-expressing myeloproliferative neoplasms (MPNs). INCA033989 demonstrated rapid, clinically meaningful responses and consistent molecular activity across both myelofibrosis (MF) and essential thrombocythemia (ET), with convergent evidence supporting the potential for disease modification. These findings are being presented in oral and poster presentations at the European Hematology Association (EHA) 2026 Congress in Stockholm, Sweden (Session: Myeloproliferative neoplasms – Clinical, Presentation numbers: S216, PS1983, PF884). “The data presented at EHA 2026 demonstrate clinically meaningful and consistent responses with INCA033989 across both myelofibrosis and essential thrombocythemia,” said Pablo J. Cagnoni, M.D., President of Incyte and G

Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 13:00:00 EEST | Press release

Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP, the current standard of care, as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. These data are being highlighted in a prestigious Plenary Abstracts Session at the European Hematology Association (EHA) 2026 Congress, being held June 11 - 14, 2026, in Stockholm, Sweden (Abstract # S101. Plenary Abstract Session. June 13, 6:00 - 7:30 a.m. ET [12:00-1:30 p.m. CEST]). frontMIND results were als

Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202613.6.2026 00:31:00 EEST | Press release

Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til

IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 19:36:00 EEST | Press release

IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, strategy, and business transformation. She most recently served as Global Head of Deloitte Digital and previously held senior global leadership roles,

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye